TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A study published in Nature Communications links the gut bacteria-produced molecule imidazole propionate, or ImP, to Alzheimer’s-related protein changes in mice and faster cognitive decline among people with higher blood levels. The human findings are observational, so they do not establish that ImP causes Alzheimer’s or show that lowering it would prevent disease.
Researchers report that imidazole propionate (ImP), a molecule produced by some gut bacteria, was linked to Alzheimer’s-related protein changes in mice and to faster cognitive decline among people with higher blood levels. The study, published in Nature Communications, points to ImP as a possible research target, but its human findings do not show that the molecule causes Alzheimer’s disease.
The team, led by researchers at the University of Wisconsin-Madison, studied ImP because earlier work had found that gut microbial communities differ between people with Alzheimer’s disease and healthy individuals. Some intestinal bacteria produce ImP while using histidine, an amino acid. The molecule can enter the bloodstream and reach parts of the body beyond the gut.
In experiments with mice, the researchers found that ImP reaching the brain increased the accumulation of abnormal beta-amyloid and tau, proteins associated with Alzheimer’s disease. Those animal results show an effect in the model studied; they do not establish that the same process causes disease in people.
The researchers also analyzed blood samples from almost 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies through the Wisconsin Alzheimer’s Disease Research Center. Higher ImP levels were associated with biological markers linked to abnormal proteins and impaired neuron function. Participants with the highest levels also showed faster decline on cognitive tests completed over time, according to the team.
A Possible Target Beyond Diet
The findings connect a measurable molecule in the bloodstream with both animal brain changes and human cognitive data. That gives researchers a specific pathway to investigate in a field where the causes and progression of Alzheimer’s are complex. If later studies confirm that ImP contributes to disease processes, treatments aimed at reducing its levels could offer a new line of research into prevention or slowing decline.
The study does not establish that lowering ImP would reduce a person’s risk, and it does not support changing diet as a way to prevent Alzheimer’s. The researchers note that histidine is an essential amino acid found in many foods, especially protein-rich foods, so simply avoiding particular foods is not a straightforward way to reduce ImP production. Any treatment idea remains speculative and untested as a prevention strategy in people.
As an affiliate, we earn on qualifying purchases.
From Gut Microbes to Brain
Nearly a decade before this report, a team led by University of Wisconsin-Madison professors Barbara Bendlin and Federico Rey reported differences in gut microorganisms between people with Alzheimer’s and healthy individuals. Their subsequent work has examined how those differences might relate to the brain.
ImP production varies between people. The researchers said bacteria capable of producing it are present in many people but are generally not abundant. Previous research has associated ImP with type 2 diabetes and coronary artery disease; the new study examines possible links to brain changes and cognition.
The study also identified a genetic variation associated with substantially higher blood ImP. About 43% of participants carried the variation. The researchers suspect it may affect how efficiently the kidneys clear ImP, but that explanation is not established by the reported association. The variation had previously been associated with Alzheimer’s risk in large genetic studies, according to Rey.
“Generally improving your diet would probably help. But it’s not as easy as saying, ‘Stop eating eggs’ or ‘Don’t eat so much red meat.’ Because you need histidine, and it’s all over the place.”
— Barbara Bendlin, University of Wisconsin-Madison professor of medicine
As an affiliate, we earn on qualifying purchases.
Cause and Treatment Remain Open
The human data show an association between blood ImP and cognitive decline; they do not prove that ImP caused that decline. The available report does not establish whether higher ImP precedes Alzheimer’s-related changes, results from other factors, or reflects a combination of influences. The mouse experiments offer evidence of an effect in animals, but do not confirm the same effect in humans.
It is also not clear whether the genetic variation raises ImP by changing kidney clearance, or how much that mechanism contributes to Alzheimer’s risk. No ImP-lowering treatment was tested, and researchers have not shown that reducing the molecule prevents disease or slows decline. The study does not provide a practical blood-level threshold for individual risk assessment.
As an affiliate, we earn on qualifying purchases.
Testing ImP as a Treatment Target
The next steps are to test the proposed biological pathway in further research and determine whether ImP levels can be safely and specifically lowered. Researchers would also need to establish whether lowering the molecule changes Alzheimer’s-related markers or cognitive outcomes in people. Until such evidence is available, the findings are a research lead, not a prevention recommendation.
The study involved collaborators from the University of California, Los Angeles, and the University of Gothenburg. It received support in part from the Wisconsin Partnership Program, the U.S. National Institutes of Health, and the U.S. Department of Agriculture.
Alzheimer's prevention supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is imidazole propionate?
Imidazole propionate, or ImP, is a molecule produced by some gut bacteria as they use histidine, an amino acid. It can enter the bloodstream.
Does the study prove ImP causes Alzheimer’s in people?
No. The human results show an association between higher blood ImP and faster cognitive decline, not proof of cause. The reported effects on beta-amyloid and tau were found in mice.
Should people change their diet to lower ImP?
The study does not establish a diet that lowers Alzheimer’s risk by reducing ImP. The researchers said avoiding foods rich in histidine is not a simple solution because histidine is essential and found in many foods.
Could an ImP-lowering drug prevent Alzheimer’s?
That is a possibility raised by the researchers, not a proven treatment. The study did not test an ImP-lowering drug or show that reducing ImP prevents Alzheimer’s or slows cognitive decline.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
